~~<i id='F5D35EC5DC'><strike id='F5D35EC5DC'><tt id='F5D35EC5DC'><pre id='F5D35EC5DC'></pre></tt></strike></i>~~

Home» leisure time» focus

focus

author：explore 2025-09-27 14:50:34 Page View：23

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Unmasking the 'centricity' illusion in clinical trials
Next article： Medical records are filled with copy

explore

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

Bird flu makes raw milk dangerous to consume, mouse study finds

JoNelAleccia/APAnewstudypublishedFridayprovidesmoreevidenceofthepotentialdangerofdrinkingunpasteuriz

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Ahumanpapillomavirus(HPV)infectionofthecevrix.WellcomeYou’dthinkiftherewereavaccinethatwouldpreventt

WSS

focus

focus

Wikipedia

explore

The HPV vaccine prevents cancer in men, too. Why do so few people get it?